TOP2A and cancer: Studies have shown that when DNA damage occurs in cancer cells, nuclear transglutaminase 2 can rapidly accumulate at DNA double-strand break sites, and directly interact with TOP2A to promote DNA double-strand break repair, which will lead to drug resistance in cancer cells [46,47,48].